# HOUSE_OVERSIGHT_027074

## Document Metadata

**Bates Range:** HOUSE_OVERSIGHT_027074 to HOUSE_OVERSIGHT_027093  
**Pages:** 39  
**Custodian:** Epstein, Jeffrey  
**Date Created:** 07/27/2016  
**Original Filename:** The case for the Female Condom 2018.pptx  
**File Type:** PPTX  
**File Size:** 2.0 MB  
**MD5 Hash:** `b30d70600847a33031eb82389c3e4eb7`

**Subject:** PowerPoint-presentatie  

## Entities Mentioned

### People
- [Saharan Africa](../entities/people/saharan-africa.md) - 1 mention
- [Mr. 
Trump](../entities/people/mr-trump.md) - 1 mention

### Organizations
- [FDA](../entities/organizations/fda.md) - 2 mentions
- [USAID](../entities/organizations/usaid.md) - 1 mention

### Locations
- [Kenya](../entities/locations/kenya.md) - 2 mentions
- [Nigeria](../entities/locations/nigeria.md) - 2 mentions
- [Haiti](../entities/locations/haiti.md) - 1 mention
- [Bolivia](../entities/locations/bolivia.md) - 1 mention
- [Tanzania](../entities/locations/tanzania.md) - 1 mention
- [Ethiopia](../entities/locations/ethiopia.md) - 1 mention
- [Uganda](../entities/locations/uganda.md) - 1 mention
- [Uruguay](../entities/locations/uruguay.md) - 1 mention
- [US](../entities/locations/us.md) - 1 mention

### Events/Dates
- [2017](../entities/events/2017.md) - 5 mentions
- [12 months](../entities/events/12-months.md) - 2 mentions
- [today](../entities/events/today.md) - 1 mention
- [2014](../entities/events/2014.md) - 1 mention
- [each year](../entities/events/each-year.md) - 1 mention
- [six months](../entities/events/six-months.md) - 1 mention
- [one month](../entities/events/one-month.md) - 1 mention
- [hours](../entities/events/hours.md) - 1 mention

## Document Text

```
﻿

The case for the FC2 female condom
 the female health company
                    
                    
                    
                    







Overview







• Commodity Context
• Contextual overview
• Debunking myths through evidence
                    
                    







                    www.femalecondom.com
Get Inspired

https://fc2femalecondom.com/get-inspired/
https://youtu.be/O0V-KYyTza8
                    
                    







ASK
Due to the funding decrease UNFPA is experiencing as the US pulled all their funding under president Trump, and the European countries have re-directed their funding to deal with the migrant influx, there is a funding shortfall leading to Female Condom stock outs in countries. 

The Female Health Company is looking for donors who are willing to donate money to UNFPA, and earmark that money for purchase of the FC2 female condom only, so that they can purchase the FC2 female condom for the following countries:
**Uganda** : 3 million units		Ghana: 1 million units
Botswana: 1 million units		Tunesia: 1 million units
Sierra Leone: 500,000 units		**Bolivia**: 500,000 units
**Tanzania**: 1 million units		**Haiti**: 500,000 units
**Ethiopia**: 1 million units		Congo DR: 2 million units

                    
                    







                    
                    
The Female Health Company provides the FC2 female condom.  

FC2 is the only product currently available:

▪ Under a women’s control 
▪ Offering triple protection:
     ▪ Against HIV/AIDS
     ▪ STIs (as well as ZIKA)
     ▪ Unplanned pregnancy
▪ Approved by the **FDA** and WHO, as well as other international and national health agencies

                    5








                    
                    







Widest possible choice
FC2 falls under Reproductive Health Supply commodities with UNFPA Supplies:

• Contraceptives
- Combined low dose OC Pills		- Implantable Contraceptives
- Emergency Contraceptives		- Injectable Contraceptives
- Female Condoms			- Intrauterine Device (IUD)
- Lubricants			- Male Condoms
- Progestogen only Pills

• Diagnostic Test Kits
• Kits
• Medical Devices
• Pharmaceutical Devices

                    
                    







Male and female condom markets
Male Condom Market Global Public sector:  10 billion
Male Condom Market FP2020, 69 countries: 1-1,6 billion
Female Condom Market: 30-60 million
FC is 3%-6% of FP2020  condom market and 0,3%-0,6% of global condom market

                    
                    







Customers and Distribution
Key purchasers:
▪ Global agencies




▪ Government/ Ministries of Health 
▪ State and local health departments/agencies
▪ NGOs and CBOs/IPPF/MSI
▪ Distributors who hold registration for FC2
▪ Social marketing organizations such as PSI and DKT
▪ Commercial partners that promote to consumers

                    
                    







Why Female condoms?
The female condom is the only female initiated method that provides triple protection against STIs including HIV and Zika and against unplanned pregnancy
Introduction of male and female condoms in the same market leads to more overall protected sex acts
Cost effective, positive return on investment

                    
                    







HIV/AIDS global overview
• No. 1 cause of death globally for women age 15-44
• 80% of female cases contracted via heterosexual transmission
• Male and female condoms are the only prevention products available

                                        Worldwide, women represent >50% of new  
                                        Adult HIV/AIDS infections
                    
                    







The social case for FC2
Empowering women as a development tool by decreasing maternal mortality & fewer unwanted pregnancies and protecting from HIV-infection, and other STIs

  ▪ Worldwide 215 million women who like to plan or limit number of children have no access to contraception
  ▪ Worldwide 21.6 million unsafe abortions cause 5 million women hospitalized **each year**, and account for 13 % of maternal deaths
  ▪ Worldwide women and girls account for slightly more than half of all HIV infections
  ▪ In sub-**Saharan Africa** 23 million people live with HIV/AIDS: over 12 million are women and nearly 2.5 million are children

                    
                    







The product case for fc2
Only **FDA** and WHO approved Female Condom and as a result approved for bulk procurement by UNFPA and **USAID**
The strong preference for FC2 due to its non allergenic material nitrile and long standing reputation
FC2 is has been distributed to 144 countries. 
The backup support, materials, training provided by FHC

                    
                    







The product case for fc2 (2)
5) The FC2 female condom, as opposed to the latex male condom, is made out of Nitrile which holds many benefits: 
- Three times stronger than latex, 
- Can be used by people who are latex sensitive, or allergic
- Can hold both water and oi
```

*[Text truncated to 5000 characters]*

---

## Related Documents

**Parent Document:** [HOUSE_OVERSIGHT_027071](HOUSE_OVERSIGHT_027071.md)

**Similar Documents** (by shared entities):
- [HOUSE_OVERSIGHT_019233](HOUSE_OVERSIGHT_019233.md) - 9 shared entities
- [HOUSE_OVERSIGHT_028621](HOUSE_OVERSIGHT_028621.md) - 8 shared entities
- [HOUSE_OVERSIGHT_020824](HOUSE_OVERSIGHT_020824.md) - 8 shared entities
- [HOUSE_OVERSIGHT_027849](HOUSE_OVERSIGHT_027849.md) - 7 shared entities
- [HOUSE_OVERSIGHT_027071](HOUSE_OVERSIGHT_027071.md) - 7 shared entities
